Search

Author/Creator Sanches, Jose

1. Brentuximab vedotin (BV) versus physician's choice (PC) of methotrexate or bexarotene in adult patients with previously treated CD30-positive cutaneous T-cell lymphoma (CTCL; mycosis fungoides [MF] or primary cutaneous anaplastic large cell lymphoma [pcALCL]): final time to next therapy (TTNT) results from the phase 3 ALCANZA study. (2019)

Authors:
Scarisbrick, Julia; Horwitz, Steven M.; Prince, H. Miles; Whittaker, Sean; Duvic, Madeleine; Kim, Youn H.; Quaglino, Pietro; Zinzani, Pier Luigi; Bechter, Oliver; Eradat, Herbert; Pinter-Brown, Lauren; Akilov, Oleg; Geskin, Larisa; Sanches, Jose; Ortiz-Romero, Pablo; Lisano, Julie; Brown, Lisa; B...
Journal:
European journal of cancer
Issue:
Volume 119(2019)Supplement 1
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Defining B2 involvement in Sezary syndrome results from the PROCLIPI study. (2019)

Authors:
Hunjan, Manrup; Bagot, Martine; Guenova, Emmanuella; Horwitz, Steve; Quaglino, Pietro; Child, Fiona; Berti, Emilio; Ortiz, Pablo; Servitje, Octavio; Marschalko, Marta; Papadavid, Evangelina; Beylot-Barry, Marie; Cowan, Richard; Estrach, Teresa; Hodak, Emelia; Akilov, Oleg; Querfeld, Christiane; V...
Journal:
European journal of cancer
Issue:
Volume 119(2019)Supplement 1
Page Start:
S6
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search